Increasingly pharmaceutical companies are looking for new ways to interact in a direct-to-consumer model.  Key communications opportunities are to:

·         advance promotional needs including Drug Assistance, Drug Treatment and Direct to Patient programs

·         disease state education,  disease management and medication adherence programs

·         promote new joint sponsorship programs with retailers, MCO’s and others on both an opt-in and opt-out basis.

·         advance Research & Development including adherence programs for patients enrolled in clinical trials, e-Diaries management and outcomes research

Automated proactive communications are at the center for the support, deployment and success of these initiatives.